253.40
-10.35
(-3.92%)
As of 8:00:44 AM GMT+2. Market Open.
Loading Chart for AMG.MU
- Previous Close
263.75 - Open
253.40 - Bid 249.95 x --
- Ask 252.35 x --
- Day's Range
253.40 - 253.40 - 52 Week Range
246.25 - 311.05 - Volume
0 - Avg. Volume
7 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: AMG.MU
View MorePerformance Overview: AMG.MU
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
AMG.MU
1.47%
S&P 500 (^GSPC)
15.28%
1-Year Return
AMG.MU
5.79%
S&P 500 (^GSPC)
4.36%
3-Year Return
AMG.MU
21.23%
S&P 500 (^GSPC)
11.02%
5-Year Return
AMG.MU
51.08%
S&P 500 (^GSPC)
78.61%
Compare To: AMG.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
19.85
-2.71%
Mkt Cap EUR 19.503B
Industry Drug Manufacturers—General
Statistics: AMG.MU
View MoreValuation Measures
As of 4/8/2025
Market Cap
137.95B
Enterprise Value
182.04B
Trailing P/E
38.08
Forward P/E
13.91
PEG Ratio (5yr expected)
0.98
Price/Sales (ttm)
4.66
Price/Book (mrq)
26.31
Enterprise Value/Revenue
5.94
Enterprise Value/EBITDA
14.88
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: AMG.MU
View MoreCompany Insights: AMG.MU
Research Reports: AMG.MU
View MorePeople Also Watch
AMG.DE Amgen Inc.
249.40
-6.78%
4AB.DE AbbVie Inc.
157.40
-6.75%
AMG.F Amgen Inc.
250.00
-4.20%
AMG.DU Amgen Inc
244.75
-5.47%
BRM.DE Bristol-Myers Squibb Company
48.00
-3.77%
GIS.MU Gilead Sciences Inc
91.70
-4.57%
0R0T.IL Amgen Inc.
290.50
0.00%
AMGN.VI Amgen Inc.
250.15
-6.21%
BIIB.VI Biogen Inc.
101.85
-5.83%
AMGN.MX Amgen Inc.
6,430.00
0.00%
LLY.DE Eli Lilly and Company
650.80
-4.91%
GIS.F Gilead Sciences, Inc.
90.42
-3.93%